ODYS.NASDAQOdysightai INC

10-Q: Odysight.ai Reports Improved Gross Profit and Revenue Growth in Q2 2024

Sentiment:

Quarterly Report


Odysight.ai saw a significant increase in revenue and a shift to gross profit in the second quarter of 2024, driven by increased sales and improved pricing with a major healthcare client and growth in the Industry 4.0 sector.

Capital raiseThe company completed a private placement on July 16, 2024, raising approximately $10.3 million.The company expects to need substantial additional funding in connection with its continuing operations.
Better than expectedThe company's revenue increased by 40% year-over-year.The company moved from a gross loss to a gross profit.The company's operating loss decreased slightly.

Summary

  • Odysight.ai reported a revenue of $1.368 million for the six months ended June 30, 2024, a 40% increase compared to the same period in 2023.
  • The company achieved a gross profit of $291,000 for the first six months of 2024, a significant improvement from a gross loss of $350,000 in the same period of 2023.
  • Operating loss decreased slightly to $5.728 million for the six months ended June 30, 2024, compared to $5.898 million in the same period of 2023.
  • Research and development expenses increased by 8% to $2.975 million, while sales and marketing expenses decreased by 31% to $459,000 for the six months ended June 30, 2024.
  • General and administrative expenses increased by 22% to $2.585 million for the six months ended June 30, 2024.
  • The company's cash and cash equivalents and restricted cash totaled $13.552 million as of June 30, 2024.
  • The company had an accumulated deficit of $39.551 million as of June 30, 2024.

Sentiment

Score: 7

Explanation: The document shows positive trends in revenue and profitability, but the company still faces challenges with losses and the need for additional funding. The recent capital raise is a positive sign, but the company's long-term financial stability remains a concern.

Positives

  • The company experienced a significant increase in revenue, driven by a major healthcare client and the Industry 4.0 sector.
  • The company achieved a gross profit, a substantial improvement from the previous year's gross loss.
  • The company reduced its operating loss compared to the same period last year.
  • The company successfully raised $10.3 million in a private placement after the reporting period.
  • The company saw a decrease in cost of revenues due to reduced material prices and improved production processes.

Negatives

  • The company continues to operate at a loss, with a net loss of $5.344 million for the six months ended June 30, 2024.
  • The company has an accumulated deficit of $39.551 million as of June 30, 2024.
  • Research and development expenses increased by 8% to $2.975 million for the six months ended June 30, 2024.
  • General and administrative expenses increased by 22% to $2.585 million for the six months ended June 30, 2024.

Risks

  • The company is dependent on a limited number of customers for a substantial portion of its revenue.
  • The company expects to continue to incur significant research and development and other costs.
  • The company will need to obtain additional funding to continue its operations until it becomes profitable.
  • The company may face challenges in raising sufficient capital on acceptable terms.
  • The company may be forced to delay, reduce, or eliminate its research and development programs or future commercialization efforts if it cannot raise sufficient capital.

Future Outlook

The company plans to continue investing in long-term growth and expects expenses to increase, particularly in research and development and commercialization. They anticipate needing additional funding to support ongoing operations and growth.

Management Comments

  • The company's primary business activity during the last few months was enlarging our focus on R&D activities in the domain of I4.0.
  • The main effect of this activity was to enable the Company to accelerate its growth and support the anticipated increased workload and solution development requirements.
  • The company believes its cash and cash resources will allow it to fund its operating plan through at least the next 12 months from the filing date of these Consolidated Financial Statements.

Industry Context

The company's focus on Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) aligns with the growing demand for these solutions in various industries, including aviation, transportation, and energy. The company's technology also has applications in the medical device sector, which is a growing market.

Comparison to Industry Standards

  • While specific competitor data is not provided, the shift to gross profit and revenue growth suggests Odysight.ai is making progress in its commercialization efforts.
  • The company's focus on I4.0 solutions is in line with industry trends towards automation and predictive maintenance.
  • The company's R&D spending is typical for a technology startup in its growth phase, but the need for additional funding highlights the challenges of scaling up.

Related Party Transactions

  • During the six months ended June 30, 2023, the Company received development services from Smartec R&D Ltd., a company owned by the Company's former CTO, for approximately $29 thousand.
  • Moshe (Mori) Arkin, a major stockholder and director of the Company, participated in the private placement on July 16, 2024.

Stakeholder Impact

  • Shareholders may be encouraged by the improved financial performance, but the need for additional funding could lead to dilution.
  • Employees may benefit from the company's growth and expansion.
  • Customers may benefit from the company's continued development of innovative solutions.
  • Suppliers may see increased business opportunities as the company scales up its operations.

Next Steps

  • The company plans to continue investing in long-term growth.
  • The company expects to continue research and development and scale up its I4.0 solutions.
  • The company expects to incur significant commercialization expenses related to product sales, marketing, manufacturing, and distribution.
  • The company will need to obtain substantial additional funding in connection with its continuing operations.

Key Dates

DateDescription
2020-01-01Start of a lease agreement for office space in Omer, Israel.
2020-02-01Start date for share incentive plan for employees, consultants, directors and other service providers.
2020-03-14Start date for share incentive plan for board of directors.
2020-06-22Start date for share incentive plan for employees, consultants, directors and other service providers.
2021-01-01Start of the 36-month term for the Omer office space lease agreement.
2021-03-28Date of investment and investor agreements.
2021-03-29Date of investment and investor agreements.
2021-04-01Start date for share incentive plan for board of directors.
2023-01-01Start date for share incentive plan for board of directors.
2023-03-15Date of stock purchase agreements.
2023-03-16Date of stock purchase agreements.
2023-05-01Start of a lease agreement for office space in Ramat Gan, Israel.
2023-06-25Date of amendment to lease agreements.
2024-01-01Start of the reporting period for the financial results.
2024-02-28Incorporation of D. VIEW Ltd. in Israel.
2024-06-01Start date for share incentive plan.
2024-06-30End of the reporting period for the financial results.
2024-07-16Date of the private placement of common stock.
2024-08-14Date of the quarterly report filing.

Keywords

Predictive Maintenance, Condition Based Monitoring, Industry 4.0, AI platform, video sensor, medical devices, aviation, transportation, energy, financial results

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.